Consistent with its inverse coexpression with IFT57 in thyroid carcinoma cells in vitro (Figure 6b,f), CRACD mRNA expression above the mean was associated with significant decreases in both disease-free and overall survival in TCGA papillary thyroid carcinomas (Figure 7a,b). The gene discussed is IFT57; the disease is thyroid gland carcinoma.